| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 11 | -208K | 100% | $33.65 | -$7.01M |
| Net | -11 | -208K | -100% | -$7.01M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marc Stapley | Chief Executive Officer, Director | $13.6M | -$243K | -1.76% | Dec 13, 2024 |
| Rebecca Chambers | Chief Financial Officer | $4.93M | -$888K | -15.3% | Dec 2, 2024 |
| Tina Susan Nova | President, CLIA U.S. | $4.78M | Mar 3, 2022 | ||
| Bonnie H. Anderson | Director | $4.68M | Jun 2, 2023 | ||
| Phillip G. Febbo | Chief Scientific & Med Officer | $3.63M | -$173K | -4.56% | Dec 4, 2024 |
| Annie McGuire | SVP, General Counsel | $3.21M | -$823K | -20.4% | Dec 4, 2024 |
| John Leite | Chief Commercial Officer-CLIA | $3.19M | -$240K | -7.01% | Dec 2, 2024 |
| Robert S. Epstein | Director | $1.97M | -$575K | -22.6% | Nov 12, 2024 |
| Giulia C. Kennedy | Chief Scientific & Med Officer | $1.75M | Dec 6, 2022 | ||
| Jonathan Wygant | VP, Chief Accounting Officer | $1.75M | -$257K | -12.8% | Dec 2, 2024 |
| John L. Bishop | Director | $1.28M | Jul 17, 2023 | ||
| Evan/ Fa Jones | Director | $1.21M | -$2.33M | -65.8% | Sep 19, 2024 |
| Eliav Barr | Director | $862K | Jun 13, 2024 | ||
| Jens Holstein | Director | $836K | -$268K | -24.2% | Aug 7, 2024 |
| Karin Eastham | Director | $816K | -$1.1M | -57.4% | Nov 19, 2024 |
| Muna Bhanji | Director | $712K | -$111K | -13.5% | Jun 13, 2024 |
| David Brent Shafer | Director | $541K | Sep 3, 2024 | ||
| Thomas F. Miller | Director | $521K | Sep 3, 2024 | ||
| Jane Alley | VP, Corporate Controller | $345K | May 17, 2021 | ||
| Kevin K. Gordon | Director | $231K | Jun 8, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|